Retrospective Study
Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy
World J Exp Med
11(2):17-29.
Published online Mar 20, 2021.
doi: 10.5493/wjem.v11.i2.17
Abstract (1131)
|
Core Tip (1059)
|
Article Highlights (1009)
|
Full Article (HTML) (4612)
|
Figures (1-3) (358)
|
Tables (1-9) (496)
|
Full Article (PDF)-994K (294)
|
Audio-3776K (9)
|
Peer-Review Report-297K (152)
|
Answering Reviewers-110K (148)
|
Received: 12/24/2020
|
Revised: 02/19/2021
|
Accepted: 03/12/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (14872)
|
Similar Articles (34)
|
Timeline of Article Publication (1)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open